Efficacy of the Janus kinase 1/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173-activating mutations in 3 children

Research output: Contribution to journalLetter

  • External authors:
  • Marie-Louise Frémond
  • Mathieu Paul Rodero
  • Nadia Jeremiah
  • Alexandre Belot
  • Eric Jeziorski
  • Darragh Duffy
  • Didier Bessis
  • Guilhem Cros
  • Bruno Charbit
  • Anne Hulin
  • Nihel Khoudour
  • Consuelo Modesto Caballero
  • Christine Bodemer
  • Monique Fabre
  • Laureline Berteloot
  • Muriel Le Bourgeois
  • Philippe Reix
  • Thierry Walzer
  • Despina Moshous
  • Stéphane Blanche
  • Alain Fischer
  • Brigitte Bader-Meunier
  • Fréderic Rieux-Laucat
  • Yanick Joseph Crow
  • Bénédicte Neven

Bibliographical metadata

Original languageEnglish
Pages (from-to)1752-1755
Number of pages4
JournalThe Journal of allergy and clinical immunology
Volume138
Issue number6
Early online date20 Aug 2016
DOIs
Publication statusPublished - 1 Dec 2016